HomeGeneticsConditionPoikiloderma with neutropenia
Back to Condition
Poikiloderma with neutropenia
Reviewed by Medicinsk Expert•Last updated: 2026-10-22•Condition

Poikiloderma with neutropenia

Poikiloderma with neutropenia (PN) is a rare genetic disorder characterized by distinctive skin changes and a persistent deficiency of infection-fighting white blood cells.

Description

Poikiloderma with neutropenia (PN) is a disorder that mainly affects the skin and the immune system. This condition begins with a bumpy rash that usually appears between the ages of 6 and 12 months, gradually spreading from the arms and legs to the torso and face. At about age 2, the rash fades, and the affected child is left with darker and lighter patches of skin coloring (hyperpigmentation and hypopigmentation) and small clusters of blood vessels just under the skin (telangiectases); this combination is known as poikiloderma.

Other skin problems include:

  • Unusually thick skin on the palms of the hands and soles of the feet (palmoplantar keratoderma)
  • Calcium deposits that form small nodules (calcinosis cutis), especially on the knees, elbows, or ears
  • Sores (ulcers) that do not easily heal

Affected individuals also have fingernails and toenails that are thick and abnormally shaped, fragile teeth, and low bone density.

Immune System and Respiratory Health

People with PN have chronic neutropenia, which is a persistent shortage of neutrophils. Neutrophils are a type of white blood cell that plays a role in inflammation and in fighting infection. Neutropenia makes it more difficult for the body to fight off pathogens such as bacteria and viruses. As a result, people with PN experience recurrent sinus infections and pneumonia, especially in the first few years of life. They often develop a condition called bronchiectasis, which damages the passages leading from the windpipe to the lungs and can cause breathing problems. Throughout life, affected individuals usually have a chronic cough or a reactive airway disease, such as asthma, which leads to wheezing and shortness of breath.

Cancer Risk and Physical Features

Researchers suggest that PN may increase the risk of cancer. A type of skin cancer called squamous cell carcinoma, a precancerous blood disorder known as myelodysplastic syndrome (MDS), and a blood cancer called acute myelogenous leukemia that often follows MDS have occurred in a few people with PN.

Some individuals with PN also develop unusual facial features as they grow, including a prominent forehead, widely spaced eyes, a flat or sunken appearance of the middle of the face, a small nose, and a protruding chin. Short stature and hypogonadotropic hypogonadism (a condition affecting the production of hormones that direct sexual development) can also occur.

Frequency

The prevalence of PN is unknown; only about 100 affected individuals have been described in the medical literature. Although it was first described in the Navajo population of the southwestern United States, it has since been identified in other individuals worldwide.

Causes

PN is caused by mutations in the USB1 gene. This gene provides instructions for making an enzyme that functions as an RNA exonuclease. This enzyme helps stabilize RNA and protects it from damage. Specifically, the USB1 enzyme protects a small RNA molecule called U6, which helps in the assembly of the blueprints for protein production.

Mutations in the USB1 gene are thought to lead to an enzyme whose function is impaired. As a result of the dysfunctional USB1 exonuclease, the U6 RNA is not protected from damage. The existence of tissue-specific isoforms of the enzyme may help explain why this disorder mainly affects the skin and immune system.

Inheritance

This condition is inherited in an autosomal recessive pattern, which means both copies of the gene in each cell have mutations. The parents of an individual with an autosomal recessive condition each carry one copy of the mutated gene, but they typically do not show signs and symptoms of the condition.

Frequently Asked Questions

Monthly CBCs are essential. For neutrophil counts <500 cells/µL or frequent infections, start prophylactic oral antibiotics (e.g., trimethoprim‑sulfamethoxazole) and consider weekly G‑CSF injections. Prompt treatment of sinus or respiratory infections with appropriate antibiotics is critical.
Use gentle, fragrance‑free moisturizers twice daily to keep skin hydrated. Apply a barrier ointment (e.g., zinc oxide) to pressure points and areas prone to trauma. Avoid prolonged heat exposure, and treat any fissures or minor wounds immediately with antiseptic dressings. For calcinosis nodules, low‑dose colchicine or bisphosphonates may be tried under rheumatology guidance.
If the child has two or more lower‑respiratory infections per year, order a high‑resolution chest CT to evaluate airway dilation. Baseline pulmonary function tests (spirometry) are also useful after age 5. Early detection allows physiotherapy, airway clearance techniques, and, if needed, inhaled bronchodilators or antibiotics.
Schedule dental visits every 3–4 months for preventive cleanings and fluoride varnish. Use a soft‑bristled toothbrush and non‑abrasive toothpaste; consider a night‑time mouthguard if grinding occurs. For nail fragility, keep nails trimmed short, moisturize cuticles, and avoid harsh chemicals. If nail dystrophy worsens, a dermatologist may prescribe topical keratolytics or protective nail lacquers.
Source: MedlinePlus, National Library of Medicine

MedlinePlus brings together authoritative health information from the National Library of Medicine (NLM), the National Institutes of Health (NIH), and other government agencies and health-related organizations.

Meyahealth

Ⓒ 2026. All rights reserved by MEYA